PARKCURE — Detection of therapeutic effects of GDNF-expressing mesenchymal stem cells (Q3298506)

From EU Knowledge Graph
Revision as of 11:35, 26 October 2021 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
Jump to navigation Jump to search
Project Q3298506 in Germany
Language Label Description Also known as
English
PARKCURE — Detection of therapeutic effects of GDNF-expressing mesenchymal stem cells
Project Q3298506 in Germany

    Statements

    0 references
    0 references
    374,808.26 Euro
    0 references
    749,616.52 Euro
    0 references
    50.0 percent
    0 references
    1 January 2016
    0 references
    31 August 2018
    0 references
    Charité - Universitätsmedizin Berlin Campus Mitte Cecilie-Vogt-Klinik für Molekulare Neurologie
    0 references
    0 references
    0 references

    52°30'5.47"N, 13°24'9.18"E
    0 references
    10117 - Berlin
    0 references
    Erforschung einer neuen Syntheseroute zur Generierung von struktur-reinen Core-Shell-Partikeln, die für die pharmazeutische Produktion geeignet sind, sowie umfassende Charakterisierung der Partikel mit geeigneten Methoden und Validierungsexperimenten in vitro und in vivo im Tiermodell (German)
    0 references
    Research into a new synthesis route for the generation of structurally pure core shell particles suitable for pharmaceutical production as well as comprehensive characterisation of the particles using appropriate methods and validation experiments in vitro and in vivo in the animal model (English)
    24 October 2021
    0 references

    Identifiers

    DE_TEMPORARY_1309
    0 references